Defibrillators are devices used to deliver therapeutic shock to a patient's heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations, along with the key players, has fuelled the market growth. Other factors such as technologically advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases are driving the market growth. However, frequent product recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.

The world defibrillators market is segmented on the basis of product, end user, and geography. On the basis of product, the world defibrillator market is further segmented into implantable defibrillators and external defibrillators. Implantable defibrillators are further categorized into cardiac resynchronisation therapy- defibrillator (CRT-D), transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). Among these, the T-ICDs segment dominates the overall ICD market owing to higher precision and targeted functioning. In addition, external defibrillators segment is further categorized into manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs).

On the basis of end user, the defibrillator market is segmented into hospitals, prehospital, public access market, alternative care market, and home. Geographically, the market is segmented across four major regions such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the defibrillators market. The growth in this region is mainly due to factors such as product innovations, growing number of public defibrillation programs, and rising prevalence of chronic diseases. In addition, the Asia-Pacific region is expected to emerge as the area with maximum growth potential due to the growing focus of key players in emerging economies, improving healthcare infrastructure, and rising number of cardiovascular diseases.

The report provides a comprehensive analysis of the key players operating in the world defibrillators market such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.

Key Benefits of the Report

The study provides an in-depth analysis of the world neuromodulation market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y forecasts for 2016 to 2022, considering 2015 as base.
Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.
Competitive intelligence highlights the business practices followed by leading players across various regions.
SWOT analysis studies the internal environment of the leading companies for strategy formulation.

KEY MARKET SEGMENTS:

The world defibrillators market is segmented into product, end user, and geography.

By Product

Implantable Defibrillators
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
External Defibrillators
Manual External Defibrillator
Automated External Defibrillator (AEDs),
Wearable Cardioverter Defibrillator (WCDs).

By End User

Hospitals
Pre-hospitals
Public Access market
Alternate Care Market
Home

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Egypt
Israel
South Africa